- Stocks
- Cement & Materials
- Eiko Lifescienc
Eiko Lifescienc share price
NSE: EIKOCement & MaterialsSpecialty Chemicals
Eiko Lifescienc at a glance
With a market capitalisation of ₹74 Cr, it ranks 2833rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Specialty Chemicals.
Its return on equity was 3.7% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹18 Cr (+62.7% year on year) and net profit ₹2 Cr (+30.8%), on a consolidated basis. Promoters held 39.91% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹74 CrRank 2833 on NSE
- Price to book
- 1.27×FY25
- EPS (TTM)
- ₹3.25to Q4 FY26
- ROE
- 3.7%FY25
- ROCE
- 4.6%FY25
- Debt to equity
- 0.05FY25
- Net profit margin
- 5.8%FY25
- Book value / share
- ₹41.26FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Eiko Lifescienc quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹11 Cr | ₹8 Cr | ₹7 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr |
| Revenue YoY | — | — | — | — | −0.4% | +43.0% | +59.9% | +62.7% |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Net profit YoY | — | — | — | — | +217.1% | +376.9% | +247.5% | +30.8% |
| Net margin | 3.3% | 3.2% | 5.3% | 10.4% | 10.4% | 10.6% | 11.6% | 8.3% |
| EPS | ₹0.25 | ₹0.22 | ₹0.32 | ₹0.80 | ₹0.66 | ₹0.78 | ₹0.88 | ₹0.93 |
Eiko Lifescienc financials
| Item | FY18 | FY19 | FY20 | FY25 |
|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹4 Cr | ₹11 Cr | ₹38 Cr |
| Operating profit | ₹0 Cr | −₹1 Cr | −₹5 Cr | ₹3 Cr |
| Net profit | ₹0 Cr | −₹1 Cr | −₹4 Cr | ₹2 Cr |
| EPS (₹) | ₹1.00 | −₹1.00 | −₹5.00 | ₹2.00 |
| Cash from operations | ₹0 Cr | ₹0 Cr | −₹0 Cr | ₹3 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹2 Cr |
| Shareholders' equity | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹57 Cr |
Eiko Lifescienc shareholding pattern
| Holder | 8 Aug 2025 | 30 Sep 2025 | 31 Dec 2025 | 24 Feb 2026 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 37.11% | 37.17% | 37.17% | 39.91% | 39.91% | 39.91% |
| Non-institutions | 62.89% | 62.83% | 62.83% | 60.09% | 60.09% | 60.09% |
Eiko Lifescienc vs peers
The listed Cement & Materials companies nearest to Eiko Lifescienc by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| KAKATCEMKakatiya Cement Sugar & Industries | ₹96.40 | +1.47% | −31.4% | ₹75 Cr | — | — |
| TOKYOPLASTTokyo Plast International | ₹78.39 | +0.44% | −38.5% | ₹74 Cr | 118.8 | — |
| EIKOEiko Lifescienc | — | — | — | ₹74 Cr | — | — |
| VINEETLABVineet Laboratories | ₹38.24 | −0.34% | +11.6% | ₹73 Cr | — | — |
| FIBERWEBFiberweb (India) | ₹25.35 | +1.16% | −39.0% | ₹73 Cr | 7.3 | — |
| KHAITANLTDKhaitan (India) | ₹151.00 | +6.33% | +16.2% | ₹72 Cr | 21.3 | — |
| KKALPANAINDKkalpana Ind | — | — | — | ₹72 Cr | — | — |
Ask anything about Eiko Lifescienc
Pivot answers on the live chart with evidence you can check, and tests strategies against EIKO's own history. Try: “Why has EIKO moved over the last three months?” · “Backtest a 50-day moving-average crossover on EIKO over five years” · “Compare EIKO with KAKATCEM on margins and valuation”
Frequently asked questions about Eiko Lifescienc
What is the market cap of Eiko Lifescienc?
Eiko Lifescienc's market capitalisation is ₹74 Cr (₹74 Cr) at the 22 Oct 2026 close, ranking 2833rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Eiko Lifescienc?
Return on equity was 3.7% in FY25 and return on capital employed was 4.6% in FY25 (consolidated figures).
Is Eiko Lifescienc a debt-free company?
Eiko Lifescienc is close to debt-free: its debt-to-equity ratio was 0.05 in FY25.
What were Eiko Lifescienc's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Eiko Lifescienc reported revenue of ₹18 Cr, +62.7% year on year, and net profit of ₹2 Cr, +30.8% year on year.
What is the shareholding pattern of Eiko Lifescienc?
As of 30 Jun 2026: promoters 39.91%, non-institutions 60.09%.
Who are Eiko Lifescienc's competitors?
The listed Cement & Materials companies closest to Eiko Lifescienc by market cap are Kakatiya Cement Sugar & Industries, Tokyo Plast International, Vineet Laboratories, Fiberweb (India), Khaitan (India) and Kkalpana Ind.
Is Eiko Lifescienc a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Eiko Lifescienc's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on EIKO against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Cement & Materials stocks · companies starting with E · all NSE stocks · this page as text